129 related articles for article (PubMed ID: 28887105)
1. The significance of polymorphism and expression of oestrogen metabolism-related genes in Chinese women with premature ovarian insufficiency.
Qin C; Chen Y; Lin Q; Yao J; Wu W; Xie J
Reprod Biomed Online; 2017 Nov; 35(5):609-615. PubMed ID: 28887105
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility.
Huang CS; Chern HD; Chang KJ; Cheng CW; Hsu SM; Shen CY
Cancer Res; 1999 Oct; 59(19):4870-5. PubMed ID: 10519398
[TBL] [Abstract][Full Text] [Related]
3. Possible risk modification by polymorphisms of estrogen metabolizing genes in familial breast cancer susceptibility in an Indian population.
Syamala VS; Syamala V; Sheeja VR; Kuttan R; Balakrishnan R; Ankathil R
Cancer Invest; 2010 Mar; 28(3):304-11. PubMed ID: 19863350
[TBL] [Abstract][Full Text] [Related]
4. COMT polymorphism influences decrease of ovarian follicles and emerges as a predictive factor for premature ovarian insufficiency.
Cordts EB; Santos MC; Peluso C; Kayaki EA; Bianco B; Barbosa CP; Christofolini DM
J Ovarian Res; 2014; 7():47. PubMed ID: 24808926
[TBL] [Abstract][Full Text] [Related]
5. CYP17, CYP1A1 and COMT polymorphisms and the risk of adenomyosis and endometriosis in Taiwanese women.
Juo SH; Wang TN; Lee JN; Wu MT; Long CY; Tsai EM
Hum Reprod; 2006 Jun; 21(6):1498-502. PubMed ID: 16527884
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms of the estrogen-metabolizing genes CYP17 and catechol-O-methyltransferase and risk of epithelial ovarian cancer.
Garner EI; Stokes EE; Berkowitz RS; Mok SC; Cramer DW
Cancer Res; 2002 Jun; 62(11):3058-62. PubMed ID: 12036914
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms of estrogen-metabolizing genes and breast cancer risk: a multigenic study.
Han DF; Zhou X; Hu MB; Xie W; Mao ZF; Chen DE; Liu F; Zheng F
Chin Med J (Engl); 2005 Sep; 118(18):1507-16. PubMed ID: 16232327
[TBL] [Abstract][Full Text] [Related]
8. CYP1A1, SULT1A1, and SULT1E1 polymorphisms are risk factors for endometrial cancer susceptibility.
Hirata H; Hinoda Y; Okayama N; Suehiro Y; Kawamoto K; Kikuno N; Rabban JT; Chen LM; Dahiya R
Cancer; 2008 May; 112(9):1964-73. PubMed ID: 18318428
[TBL] [Abstract][Full Text] [Related]
9. [Study on the relationship between polymorphisms of genes (CYP17, CYP19 and SULT1A1) and susceptibility to breast cancer in Chinese women].
Hu MB; Xie W; Xiong B; Han DF; Li Y; Feng MH; Zhou YF
Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Apr; 27(4):351-5. PubMed ID: 16875543
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in CYP17, COMT, and ESR1 genes in women after menopause and association with bone mineral density.
Gonçalves CG; Almeida BC; Camargo-Kosugi CM; Costa AM; Silva ID; Haidar MA
Genet Mol Res; 2015 Dec; 14(4):15802-10. PubMed ID: 26634548
[TBL] [Abstract][Full Text] [Related]
11. CYP17 and COMT gene polymorphisms can influence bone directly, or indirectly through their effects on endogenous sex steroids, in postmenopausal Japanese women.
Gorai I; Inada M; Morinaga H; Uchiyama Y; Yamauchi H; Hirahara F; Chaki O
Bone; 2007 Jan; 40(1):28-36. PubMed ID: 16971197
[TBL] [Abstract][Full Text] [Related]
12. Two single nucleotide polymorphisms in the CYP17 and COMT Genes--relation to bone mass and longitudinal bone changes in postmenopausal women with or without hormone replacement therapy. The Danish Osteoporosis Prevention Study.
Tofteng CL; Abrahamsen B; Jensen JE; Petersen S; Teilmann J; Kindmark A; Vestergaard P; Gram J; Langdahl BL; Mosekilde L
Calcif Tissue Int; 2004 Aug; 75(2):123-32. PubMed ID: 15129369
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of SNP in estrogen-metabolizing enzymes for ovarian, endometrial, and breast cancers in Novosibirsk, Russia.
Gulyaeva LF; Mikhailova ON; PustyInyak VO; Kim IV; Gerasimov AV; Krasilnikov SE; Filipenko ML; Pechkovsky EV
Adv Exp Med Biol; 2008; 617():359-66. PubMed ID: 18497059
[TBL] [Abstract][Full Text] [Related]
14. Association study of two steroid biosynthesis genes (COMT and CYP17) with Alzheimer's disease in the Italian population.
Corbo RM; Gambina G; Broggio E; Scarabino D; Scacchi R
J Neurol Sci; 2014 Sep; 344(1-2):149-53. PubMed ID: 25012481
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms in estrogen-metabolizing genes and breast cancer survival.
Long JR; Cai Q; Shu XO; Cai H; Gao YT; Zheng W
Pharmacogenet Genomics; 2007 May; 17(5):331-8. PubMed ID: 17429315
[TBL] [Abstract][Full Text] [Related]
16. Epistatic Interaction of CYP1A1 and COMT Polymorphisms in Cervical Cancer.
Matos A; Castelão C; Pereira da Silva A; Alho I; Bicho M; Medeiros R; Bicho MC
Oxid Med Cell Longev; 2016; 2016():2769804. PubMed ID: 26798414
[TBL] [Abstract][Full Text] [Related]
17. Estrogen-metabolizing gene COMT polymorphism synergistic APOE epsilon4 allele increases the risk of Alzheimer disease.
Wang PN; Liu HC; Liu TY; Chu A; Hong CJ; Lin KN; Chi CW
Dement Geriatr Cogn Disord; 2005; 19(2-3):120-5. PubMed ID: 15591802
[TBL] [Abstract][Full Text] [Related]
18. Investigation of polymorphisms in genes involved in estrogen metabolism in menstrual migraine.
Sutherland HG; Champion M; Plays A; Stuart S; Haupt LM; Frith A; MacGregor EA; Griffiths LR
Gene; 2017 Apr; 607():36-40. PubMed ID: 28089731
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in phase I and phase II genes and breast cancer risk and relations to persistent organic pollutant exposure: a case-control study in Inuit women.
Ghisari M; Eiberg H; Long M; Bonefeld-Jørgensen EC
Environ Health; 2014 Mar; 13(1):19. PubMed ID: 24629213
[TBL] [Abstract][Full Text] [Related]
20. Estrogen sulfation genes, hormone replacement therapy, and endometrial cancer risk.
Rebbeck TR; Troxel AB; Wang Y; Walker AH; Panossian S; Gallagher S; Shatalova EG; Blanchard R; Bunin G; DeMichele A; Rubin SC; Baumgarten M; Berlin M; Schinnar R; Berlin JA; Strom BL
J Natl Cancer Inst; 2006 Sep; 98(18):1311-20. PubMed ID: 16985250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
